enVVeno Medical
NVNO
37 hedge funds and large institutions have $20.3M invested in enVVeno Medical in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
11,989% more call options, than puts
Call options by funds: $1.09M | Put options by funds: $9K
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
112% more capital invested
Capital invested by funds: $9.61M → $20.3M (+$10.7M)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
23% more funds holding
Funds holding: 30 → 37 (+7)
0.23% more ownership
Funds ownership: 0.59% → 0.83% (+0.23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$4.34M |
| 2 |
Universal-Beteiligungs- und Servicegesellschaft
Frankfurt Am Main,
Germany
|
+$676K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$329K |
| 4 |
RFC
Regions Financial Corp
Birmingham,
Alabama
|
+$231K |
| 5 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$69.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
-$186K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$185K |
| 3 |
Squarepoint
New York
|
-$109K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$43.3K |
| 5 |
JP Morgan Chase
New York
|
-$40.2K |
NVNO Hedge Fund Activity: Q2 2025 in Review
37 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2025, worth a combined $20.3M — up 112% from $9.61M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NVNO positions and 4 closed out — a net gain of 7 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $4.34M. The largest seller was Dauntless Investment Group, exiting entirely with an estimated $186K sold.
- 37 institutional investors held enVVeno Medical (NVNO) as of Q2 2025, up from 30 in Q1 2025.
- Funds reported $20.3M of enVVeno Medical stock for Q2 2025, up 112% quarter-over-quarter.
- 11 funds opened new enVVeno Medical positions in Q2 2025 and 4 closed out, a net change of +7 holders.
- The largest enVVeno Medical buyer in Q2 2025 was Perceptive Advisors, an estimated $4.34M added.
- The largest enVVeno Medical seller in Q2 2025 was Dauntless Investment Group, an estimated $186K sold.
Based on aggregated 13F filings for Q2 2025.